CARAGLIA, MICHELE
Distribuzione geografica
Continente | # |
---|---|
NA - Nord America | 327 |
EU - Europa | 54 |
AS - Asia | 17 |
AF - Africa | 4 |
SA - Sud America | 1 |
Totale | 403 |
Nazione | # |
---|---|
US - Stati Uniti d'America | 322 |
IE - Irlanda | 19 |
IT - Italia | 13 |
VN - Vietnam | 10 |
FR - Francia | 8 |
CN - Cina | 6 |
CA - Canada | 5 |
ZA - Sudafrica | 4 |
DE - Germania | 3 |
GB - Regno Unito | 2 |
NL - Olanda | 2 |
SE - Svezia | 2 |
AT - Austria | 1 |
CL - Cile | 1 |
ES - Italia | 1 |
FI - Finlandia | 1 |
IN - India | 1 |
LT - Lituania | 1 |
UA - Ucraina | 1 |
Totale | 403 |
Città | # |
---|---|
Fairfield | 49 |
Seattle | 25 |
Redmond | 24 |
Woodbridge | 21 |
Buffalo | 20 |
Ashburn | 19 |
Cambridge | 18 |
Dublin | 18 |
Santa Cruz | 18 |
Wilmington | 13 |
Houston | 12 |
Las Vegas | 10 |
Dong Ket | 9 |
Siena | 7 |
Clearwater | 5 |
Columbus | 5 |
Florence | 5 |
Riva | 5 |
Ann Arbor | 3 |
Muizenberg | 3 |
New York | 3 |
Phoenix | 3 |
Boardman | 2 |
Chicago | 2 |
Easton | 2 |
Lake Forest | 2 |
Nanjing | 2 |
Ottawa | 2 |
San Diego | 2 |
San Francisco | 2 |
Shanghai | 2 |
Stockholm | 2 |
Toronto | 2 |
University Park | 2 |
Barcelona | 1 |
Bengaluru | 1 |
Büdelsdorf | 1 |
Dallas | 1 |
Frankfurt am Main | 1 |
Giussano | 1 |
Helsinki | 1 |
Ho Chi Minh City | 1 |
Indiana | 1 |
Lombard | 1 |
Menlo Park | 1 |
Milpitas | 1 |
Reston | 1 |
Salem | 1 |
San Jose | 1 |
Silverton | 1 |
Southend | 1 |
Tianjin | 1 |
Vienna | 1 |
Wuhan | 1 |
Yellow Springs | 1 |
Totale | 340 |
Nome | # |
---|---|
Anti-cancer activity of dose-fractioned mPE +/- bevacizumab regimen is paralleled by immune-modulation in advanced squamous NSLC patients, file e0feeaa6-bb8b-44d2-e053-6605fe0a8db0 | 162 |
Systemic inflammatory status predict the outcome of k-RAS WT metastatic colorectal cancer patients receiving the thymidylate synthase poly-epitope-peptide anticancer vaccine, file e0feeaa7-deba-44d2-e053-6605fe0a8db0 | 134 |
Radiotherapy prolongs the survival of advanced non-small-cell lung cancer patients undergone to an immune-modulating treatment with dose-fractioned cisplatin and metronomic etoposide and bevacizumab (mPEBev)., file e0feeaa7-6829-44d2-e053-6605fe0a8db0 | 120 |
HLA Expression Correlates to the Risk of Immune Checkpoint Inhibitor-Induced Pneumonitis, file ca371d2a-ec7a-485f-9b98-207f7ed9ecf5 | 5 |
Immuno-Inflammatory Markers in Advanced NSCLC Patients Undergone Fractioned Cisplatin, Oral Etoposide and Bevacizumab, file e0feeaa7-92d0-44d2-e053-6605fe0a8db0 | 2 |
Totale | 423 |
Categoria | # |
---|---|
all - tutte | 1.095 |
article - articoli | 0 |
book - libri | 0 |
conference - conferenze | 0 |
curatela - curatele | 0 |
other - altro | 0 |
patent - brevetti | 0 |
selected - selezionate | 0 |
volume - volumi | 0 |
Totale | 1.095 |
Totale | Lug | Ago | Sett | Ott | Nov | Dic | Gen | Feb | Mar | Apr | Mag | Giu | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2018/2019 | 59 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 25 | 34 |
2019/2020 | 103 | 12 | 6 | 6 | 12 | 10 | 8 | 14 | 9 | 11 | 7 | 3 | 5 |
2020/2021 | 78 | 2 | 8 | 2 | 15 | 4 | 8 | 5 | 3 | 5 | 7 | 5 | 14 |
2021/2022 | 67 | 2 | 14 | 0 | 3 | 6 | 3 | 3 | 3 | 0 | 1 | 26 | 6 |
2022/2023 | 53 | 1 | 3 | 17 | 10 | 4 | 9 | 1 | 0 | 0 | 2 | 5 | 1 |
2023/2024 | 40 | 0 | 0 | 5 | 3 | 3 | 5 | 12 | 0 | 0 | 5 | 7 | 0 |
Totale | 423 |